{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:15:13Z","timestamp":1789524913720,"version":"build-2803163510"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T00:00:00Z","timestamp":1634169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1038\/s41371-021-00625-1","type":"journal-article","created":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T10:12:48Z","timestamp":1634206368000},"page":"485-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A comparative study assessing the incidence and degree of hyperkalemia in patients on angiotensin-converting enzyme inhibitors versus angiotensin-receptor blockers"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3796-866X","authenticated-orcid":false,"given":"Jonathan R.","family":"Salik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara B.","family":"Golas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,14]]},"reference":[{"key":"625_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.119.14360","volume":"75","author":"CG Derington","year":"2020","unstructured":"Derington CG, King JB, Herrick JS, Shimbo D, Kronish IM, Saseen JJ, et al. Trends in antihypertensive medication monotherapy and combination use among US adults, NHANES 2005-2016. Hypertension. 2020;75:973\u201381.","journal-title":"Hypertension."},{"key":"625_CR2","first-page":"547","volume":"5","author":"SA Sadjadi","year":"2009","unstructured":"Sadjadi SA, McMillan JI, Jaipaul N, Blakely P, Hline SS. A comparative study of the prevalence of hyperkalemia with the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers. Ther Clin Risk Manag. 2009;5:547\u201352.","journal-title":"Ther Clin Risk Manag"},{"key":"625_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41371-021-00504-9","volume":"35","author":"C Loutradis","year":"2021","unstructured":"Loutradis C, Price A, Ferroo CJ, Sarafidis P. Renin-angiotensin system blockade in patients with chronic kidney disease: benefits, problems in everyday clinical use, and open questions for advanced renal dysfunction. J Hum Hypertens. 2021;35:499\u2013509.","journal-title":"J Hum Hypertens"},{"key":"625_CR4","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1111\/j.1523-1755.2000.00381.x","volume":"58","author":"GL Bakris","year":"2000","unstructured":"Bakris GL, Siomos M, Richardson D, Janssen I, Bolton WK, Hebert L, et al. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. Kidney Int. 2000;58:2084\u201392.","journal-title":"Kidney Int"},{"key":"625_CR5","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2215\/CJN.07821109","volume":"5","author":"MR Weir","year":"2010","unstructured":"Weir MR, Rolfe M. Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors. Clin J Am Soc Nephrol. 2010;5:531\u201348.","journal-title":"Clin J Am Soc Nephrol"},{"key":"625_CR6","first-page":"5935149","volume":"22","author":"HR Jun","year":"2021","unstructured":"Jun HR, Kim H, Lee SH, Cho JH, Lee H, Yim HW, et al. Onset of hyperkalemia following the administration of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker. Cardiovasc Ther. 2021;22:5935149.","journal-title":"Cardiovasc Ther"},{"key":"625_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/phar.2051","volume":"38","author":"G Fang","year":"2018","unstructured":"Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Sturmer T, et al. Incidence of and risk factors for severe adverse events in elderly patients taking angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers after an acute myocardial infarction. Pharmacotherapy. 2018;38:29\u201341.","journal-title":"Pharmacotherapy."},{"key":"625_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2016.01.006","volume":"6","author":"M Epstein","year":"2016","unstructured":"Epstein M, Lifschitz MD. Potassium homeostasis and dyskalemias: the respective roles of renal, extrarenal, and gut sensors in potassium handling. Kidney Int Suppl. 2016;6:7\u201315.","journal-title":"Kidney Int Suppl"},{"key":"625_CR9","doi-asserted-by":"publisher","first-page":"e005428","DOI":"10.1161\/JAHA.116.005428","volume":"6","author":"G Bandak","year":"2017","unstructured":"Bandak G, Sang Y, Gasparini A, Chang AR, Ballew SH, Evans M, et al. Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) project. J Am Heart Assoc. 2017;6:e005428.","journal-title":"J Am Heart Assoc"},{"key":"625_CR10","first-page":"S212","volume":"21","author":"E Murray","year":"2015","unstructured":"Murray E, Reaven NL, Funk SE, McCaughey KJ, Oestreicher, Knispel J. Evaluation of the treatment gap between clinical guidelines and the utilization of renin-angiotensin-aldosterone system inhibitors. Am J Manag Care. 2015;21:S212\u201320.","journal-title":"Am J Manag Care"},{"key":"625_CR11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/009127002401102696","volume":"42","author":"RA Preston","year":"2002","unstructured":"Preston RA, Baltodano NM, Alonso AB, Epstein M. Comparative effects on dynamic renal potassium excretion of ACE inhibitor versus angiotensin receptor blockade in hypertensive patients with type II diabetes mellitus. J Clin Pharm. 2002;42:754\u201361.","journal-title":"J Clin Pharm"},{"key":"625_CR12","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41440-020-00580-3","volume":"44","author":"M Okada","year":"2021","unstructured":"Okada M. Big data and real-world data-based medicine in the management of hypertension. Hypertens Rev. 2021;44:147\u201353.","journal-title":"Hypertens Rev"},{"key":"625_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.semnephrol.2013.04.003","volume":"33","author":"ML Gumz","year":"2013","unstructured":"Gumz ML, Rabinowitz L. Role of circadian rhythms in potassium homeostasis. Semin Nephrol. 2013;33:229\u201336.","journal-title":"Semin Nephrol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00625-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T08:04:13Z","timestamp":1653465853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-021-00625-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,14]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1038\/s41371-021-00625-1","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,14]]},"assertion":[{"value":"2 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}